| Autor: |
Citra, Tia Mella, Pramuningtyas, Ratih, Agustina, Tri, Herawati, Erna, Mayangsari, Ayu, Fatiha, Zhela Fatin, Hariyono, Aulia Nissa Rizky |
| Předmět: |
|
| Zdroj: |
Journal Research of Social Science, Economics & Management; okt2022, Vol. 2 Issue 3, p319-327, 9p |
| Abstrakt: |
Pre-eclampsia was defined as hypertension after 20 weeks of gestation with evidence of maternal organ dysfunction, uteroplacental, or proteinuria. Maternal vitamin D deficiency may be with an increased risk of pre-eclampsia. Nonetheless, To assess the impact of vitamin D supplementation on the risk of pre-eclampsia, we performed a literature review. We researched Google Scholar; PubMed; Research Gate; and Science Directs using keywords ("Vitamin D" OR "Hydroxyvitamin D (25(OH)D)" OR "25(OH)D" OR "25hydroxycholecalciferol") AND ("Pregnancy" OR "Pregnant women" OR "Gestation") AND ("Clinical trial" OR "Clinical study" OR "study" OR "prospective study" OR "Randomized controlled trial" OR "RCT") from January 2006 - May 2021. A total of 4 of 19.431 articles were recorded at the identification stage by the criteria for inclusion. The articles are randomized controlled trials (RCT). A total of 329 pregnant women are given various vitamin D supplements with a dose range of 400 - 4.000 IU. Some articles combine with another vitamin (Calcium, Vitamin C+E) for a certain duration. Maternal ages range 20 years - 40 years with a gestational age of 6 to more than 32 weeks. Vitamin D can reduce the risk of pre-eclampsia in pregnant women. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
